Glyxambi (25mg empagliflozin / 5mg linagliptin) is a prescription oral tablet combining two diabetes medications to improve glycemic control in adults with type 2 diabetes. It works by increasing glucose excretion through urine (empagliflozin) and increasing insulin release (linagliptin). It is used alongside diet and exercise to lower blood sugar.
